Live Breaking News & Updates on Pontifax Venture Capital

Stay updated with breaking news from Pontifax venture capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline

Raises additional 16M EUR led by Dawn Biopharma, a platform controlled by KKR, with participation from existing investors.Funds will be used to further strengthen growing pipeline of first in ....

Iyona Rajkomar , Michael Pehl , Healthcare Strategic Growth Fund , Novo Holdings , Dawn Biopharma , Managing Partner , Adcendo Board , Ysios Capital , Gilde Healthcare , Pontifax Venture , Development Candidate Nomination , Chief Executive Officer , Board Director , Pontifax Venture Capital , Strategic Growth Fund , Ihr Portfolio ,

Adcendo ApS to Present Data on its Novel ADC Target uPARAP in Glioblastoma Multiforme at the American Association for Cancer Research Annual Meeting 2024

/PRNewswire/ Adcendo ApS ("Adcendo"), a biotech company focused on the development of first-in-class antibody-drug conjugates (ADCs) for the treatment of. ....

San Diego , United States , Landskapet Birkaland , Southwest Finland , Lars Engelholm , Dominik Mumberg , Cancer Research , Finsen Laboratory , Aurexel Life Sciences , Novo Holdings , Clinical Research Immunology , University Of Copenhagen , Cancer Invasion Section Of The Finsen Laboratory , American Association For Cancer Research , American Association , Annual Meeting , Chief Scientific Officer , Associate Professor , Cancer Invasion Section , Life Sciences , Ysios Capital , Pontifax Venture Capital ,

Keros Therapeutics, Inc. (NASDAQ:KROS) institutional owners may be pleased with recent gains after 2.4% loss over the past year

Key Insights Significantly high institutional ownership implies Keros Therapeutics' stock price is sensitive to their. ....

Jasbir Seehra , Keros Therapeutics Inc , Keros Therapeutics , Pontifax Venture Capital , Institutional Ownership , Institutional Investors ,

Enavate Sciences Backs Graviton Bioscience in Financing Round to Advance Development of Selective ROCK2 Inhibitors

Enavate Sciences Backs Graviton Bioscience in Financing Round to Advance Development of Selective ROCK2 Inhibitors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Doug Allen , Samuel Waksal , Gtpase Rho , Zach Kouwe , James Boylan , Julia Balanova , Eli Lilly , Enavate Sciences , Imclone Systems , Kadmon Pharmaceuticals , Enavate Sciences Contacts , Cormorant Asset Management , Pontifax Venture Capital , Ovid Therapeutics , Patient Square , Covid Therapeutic , Chief Executive Officer , Patient Square Capital , Bioscience Contact , Sciences Contacts ,

The top 5 ADC startups favoured by venture capital investors

Antibody-drug conjugates (ADC) are booming in the biotech industry this year with mounting investment and M&A deals. Here are five ADC players that have caught the eye of investors in the last 12 months. ....

United States , San Diego , Daiichi Sankyo , Rutgers New Jersey Medical School , University Of Strasbourg , French National Institute Of Health Inserm , Novo Holdings , University Of Copenhagen , Creation House Program , Bioinnovation Institute , Tagworks Pharmaceuticals , Drug Administration , Samsung Venture , Enovo Seeds , Pontifax Venture Capital , Duality Biologics , Eight Roads Ventures , French National Institute , Jeito Capital , Rutgers New Jersey Medical , Avidity Partners , Cowen Healthcare , Philips Healthcare , Ysios Capital , Markets Amp Regulations , Bio Developments ,